Cargando…
ERBB2 oncogenicity: ERBIN helps to perform the job
ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2) is an oncogenic tyrosine kinase receptor that is overexpressed in breast cancer. Antibodies and inhibitors targeting ERBB2 are currently available, although therapeutic failures remain frequent. We discuss here recent data showi...
Autores principales: | Mei, Lin, Borg, Jean-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905317/ https://www.ncbi.nlm.nih.gov/pubmed/27308480 http://dx.doi.org/10.4161/23723556.2014.995033 |
Ejemplares similares
-
CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma
por: Tardáguila, Manuel, et al.
Publicado: (2013) -
Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018) -
Oncogenic long noncoding RNA FAL1 in human cancer
por: Zhong, Xiaomin, et al.
Publicado: (2015) -
NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013) -
Getting by with a little help from the right CD4(+) T cells
por: Hoepner, Sabine, et al.
Publicado: (2013)